CMS Announces Major Changes for Medicare Advantage and Part D Programs
Discover the key regulatory changes to Medicare Advantage and Part D programs impacting insurance carriers in 2027. Ensure your compliance strategies are up-to-date.
CMS Announces 2.48% Increase in Medicare Advantage Payments for 2027
Discover the implications of the 2.48% Medicare Advantage payment increase for 2027. Learn how CMS adjustments impact insurance strategies and patient care.
Medicare Advantage Updates: CY 2027 Major Reforms Announced
Explore the significant updates to the Medicare Advantage program for CY 2027, including key regulatory changes and payment adjustments by CMS.
CMS Guidance on Medicaid Funding Restrictions for Noncitizens
CMS sets new Medicaid funding rules for noncitizens. Key changes for states with important compliance and operational guidance. Learn more about these updates.
CMS Adjusts Medicare Advantage Payments Amid Fiscal Concerns
CMS's new Medicare Advantage payment adjustment raises concerns about costs and fiscal responsibility. Learn more about its impacts on beneficiaries and industry reforms.
CMS Updates Medicare Advantage Star Ratings: New Standards for 2027
Discover the CMS revisions to Medicare Advantage star ratings, enhancing quality payments for insurers. Key updates effective in 2027 should not be missed!
Updated CMS Guidance on Organ Donation Processes and OPO Responsibilities
Explore the new CMS guidance on organ donation processes and OPO responsibilities, enhancing oversight and accountability within the healthcare system.
CMS Issues Sanctions to Elevance Health: Impacts on Medicare Advantage Plans
Elevance Health faces potential sanctions from CMS impacting Medicare Advantage enrollments. Discover the implications for financial guidance and stock performance.
AHA Responds to CMS Proposed Parameters for 2027
AHA emphasizes the need for patient protections and affordable care in response to CMS’s proposed 2027 payment parameters. Discover key insights and recommendations.
Medicare Drug Price Negotiation Insights and Implications
Explore the implications of Medicare's Drug Price Negotiation Program, its impact on costs, and the ongoing negotiations for 2028. Discover key details.